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Objective:Matrixmetalloproteinase-9 (MMP-9) has been widely described to play a critical role in aneurysm development.
The goal of this study was to determine the spatiotemporal changes in MMP-9 expression and abundance in the early
stages of aortic dilatation during the course of thoracic aortic aneurysm (TAA) formation in a mouse model.
Methods: In this study, TAAs were surgically induced in a transgenic reporter mouse strain expressing the -galactosidase
(-gal) gene under control of the MMP-9 promoter. Terminal studies were performed during the early stages of TAA
development at 1 week (n 6), 2 weeks (n 6), and 4weeks (n 6) post-TAA induction surgery. Changes in aortic outer
diameter were determined in vivo by video micrometry. MMP-9 transcriptional activity (-gal staining) and protein
content (immunohistochemistry) were quantified at each time point and expressed as a percentage of unoperated
reference control mice (n  6).
Results: Aortic dilatation was evident at 1 week and reached maximal size at 2 weeks (21%  6% increase from baseline,
P < .05). MMP-9 transcriptional activity was detected at 1 week post-TAA induction (722%  323%, P  .19), reached
amaximumwithin the adventitia at 2 weeks (1770% 505%, P< .05), and returned to baseline by 4 weeks (167% 47%,
P .21). MMP-9 transcription at 2 weeks colocalized with fibroblasts and smooth muscle cells. MMP-9 protein content
within the aortic adventitia was increased at 2 weeks post-TAA induction (413% 124%, P< .05) and remained elevated
at 4 weeks (222%  41%, P < .05). MMP-9 staining was most intense at the adventitial–medial border and could be
detected throughout the elastic media.
Conclusions: These findings demonstrate a unique spatiotemporal pattern of MMP-9 transcriptional activation and
protein content in the developing TAA. Colocalization studies suggest that early dilatation may be driven in part by
MMP-9 produced by endogenous cells residing within the aortic vascular wall. ( J Vasc Surg 2006;44:1314-21.)
Clinical Relevance: The detection of thoracic abdominal aneurysm (TAA) formation and progression remains clinically
difficult to manage. TAA development is a multifactorial process influenced by both cellular and extracellular mechanisms
that converge on common maladaptive signaling pathways that alter the vascular environment. Active remodeling of the
vascular extracellular matrix has been directly implicated in aortic dilatation and aneurysm development, and multiple
studies have shown that matrix metalloproteinase-9 (MMP-9) has a critical role in this process. Thus, the goal of this
study was to define the spatiotemporal relationship between MMP-9 expression/abundance and the initiation of aortic
dilatation in the developing TAA. Understanding when and where MMP-9 is expressed locally defines a therapeutic
window during which disruption of MMP-9 activity may aid in attenuating TAA progression.Thoracic aortic aneurysms (TAAs) are a serious and
potentially deadly disorder associated with high morbidity
and mortality.1-4 It has become increasingly appreciated
that TAA development proceeds by a multifactorial process
that drives aberrant events initiated by intracellular and
extracellular signaling pathways. These aberrant events re-
sult in the remodeling of the vascular extracellular matrix,
an invariant feature of TAA formation, and are the primary
reason for the loss of vascular integrity that results in aortic
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1314dilatation. As vital mediators of extracellular matrix remod-
eling, matrix metalloproteinases (MMPs) have been di-
rectly implicated in aneurysm formation.5-10
MMP-9 is a secreted pro-gelatinase capable of degrad-
ing many of the extracellular matrix proteins, including
collagen and elastin. As such, it has been identified as a
critical mediator of vascular remodeling and has been de-
scribed as the predominant MMP involved in the patho-
genesis of abdominal aortic aneurysms (AAA).11-13 Studies
by Thompson et al12 colocalized MMP-9 messenger RNA
(mRNA) with CD-68macrophages in human AAA tissue
taken at the time of resection and suggested that the
vascular remodeling associated with AAA may be depen-
dent on infiltrating macrophages. This was further substan-
tiated by Pyo et al,14 who demonstrated that AAA forma-
tion could be restored in MMP-9 knockout mice, which
failed to produce AAA after elastase perfusion, with wild-
type bone marrow transplantation.
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diator of AAA development by Longo et al15 when they
demonstrated that calcium chloride-induced AAA forma-
tion in MMP-9 knockout mice could be restored by infus-
ing wild-type macrophages alone. Taken together, these
data suggest that macrophages provide a significant source
of MMP-9 and have a dominant role in the development of
AAA.
Studies from our laboratory have previously demonstrated
that TAA formation was enhanced in mice carrying a targeted
deletion of the tissue inhibitor of metalloproteinase-1
(TIMP-1) gene.16 This coincided with an increase in gela-
tinase activity, suggesting that simply disrupting the stoi-
chiometric balance between active MMPs and their inhib-
itors may be sufficient to effect aneurysm formation. These
results were supported by a reciprocal study that demon-
strated a 50% reduction in aortic dilatation in MMP-9
knockout mice, thus confirming the importance ofMMP-9
in TAA formation.17 To date, however, the source of
MMP-9 in the developing TAA has not been determined.
To advance our previous observations, we therefore tested
the hypothesis that inflammatory infiltrate was critical for
MMP-9 production during TAA development. Through
the use of a unique MMP-9 reporter mouse strain and
immunohistochemical staining techniques, this study pro-
vides coordinated insight into the time-dependent expres-
sion and localization of MMP-9 within the aortic wall
during TAA formation.
METHODS
Experimental design. TAAs were surgically induced
in approximately equal numbers of male and female trans-
genic 3445[MMP-9:-gal]/CD-1 reporter mice (MMP-9 re-
porter mice). This mouse strain, originally developed by
Fini et al,18 expresses the -galactosidase gene under the
control of theMMP-9 promoter in all cells. All mice were 8
to 12 weeks old at the time of the initial procedure. De-
scending thoracic aortas were harvested at 1 week (n  6),
2 weeks (n 6), and 4 weeks (n 6) post-TAA induction.
For all studies presented in this report, age-matched non-
operated-on mice with no TAA induction were used as
reference controls (n  6); they were euthanized and their
thoracic aortas harvested in an identical fashion to all TAA-
induced animals. All animals were treated and cared for in
accordance with the National Institutes of HealthGuide for
the Care andUse of Laboratory Animals (National Research
Council, Washington, DC, 1996), and this animal protocol
was approved by the MUSC Institutional Animal Care and
Use Committee (ARC# 2146).
Operative procedure. Aortic diameters were mea-
sured at baseline and time of terminal surgery. Murine
TAAs were induced as previously described in detail.19
Briefly, mice were orotracheally intubated and maintained
under a surgical plane of anesthesia with 2% isoflurane. The
mice were then underwent fifth intercostal space thoracot-
omy with exposure of the descending thoracic aorta. A
sponge soaked in 0.5M calcium chloride was then placed in
direct contact with the distal half of the descending thoracicaorta for 15 minutes. After exposure, the sponge was
removed, the chest was irrigated, and the lung was re-
expanded. The incisions were closed, and the mice were
allowed to survive for the indicated time periods.
Aortic harvest and tissue preparation. At time of
terminal surgery, the animals were anesthetized and the
initial incisions were reopened and extended to beneath the
xiphoid process. The mice were euthanized, and the circu-
latory system was perfused with normal saline. For spatio-
temporal localization of MMP-9 transcriptional activity and
protein abundance, the entire aorta was carefully harvested
from the aortic root to the abdominal bifurcation and placed
directly into 10% formalin solution for 15 minutes. The sam-
ples were thenwashed three times for 5minutes in phosphate-
buffered saline and incubated in X-gal solution (5-bromo-4-
chloro-3-indolyl--D-galactopyranoside) for 24 hours at
40°C. At the end of the incubation, the samples were
washed again as above, fixed in Dent’s solution (80:20,
dimethylsulfoxide:methanol), and stored at 4°C until they
were paraffin-embedded and prepared in 8-m longitudi-
nal sections.
Aortic diameter measurements and architecture.
Digital images of the descending thoracic aorta were ob-
tained using a color CCD camera (KP DZ0B; Hitachi
Kokusai Electric Inc, Tokyo, Japan) linked to a laptop
computer with digital imaging software (WinTV2000,
Hauppauge Computer Works, Inc, Hauppauge, NY). Aor-
tic outer diameter measurements were made by using a
digital video caliper (DMZR; Techni-Quip, Danville,
Calif). The architecture of the thoracic aorta was assessed
by microscopy of 3-m cross-sections of aortic tissue coun-
terstained with light green under low (10) and high
(63) magnification.
Spatiotemporal localization of MMP-9. In situ
MMP-9 transcriptional activation was quantified by mea-
suring the amount of blue precipitate formed upon X-gal
cleavage by -gal. Paraffin-embedded TAA tissue was sec-
tioned longitudinally and 8-m-thick sections were counter-
stained with eosin and mounted on glass slides for analysis.
Similarly, in situ MMP-9 protein abundance was deter-
mined by immunohistochemistry using an antibody specific
for both active and latent MMP-9. Paraffin-embedded
longitudinal sections (8-m thick) were mounted on glass
slides, blocked with 3% bovine serum albumin, and reacted
with a 1:250 dilution of rabbit antimouseMMP-9 antibody
(#Ab19047, Upstate/CHEMICON, Temecula, Calif).
The slides were then washed and reacted with a 1:200
dilution of goat-antirabbit-peroxidase conjugated secondary
antibody (Vectastain ABC kit, Vector Labs, Burlingame,
Calif). Positive MMP-9 protein staining was visualized by
incubation with 3,3=-diaminobenzidine (DAB), which
formed a brown precipitate upon reaction with the perox-
idase-conjugated secondary antibody. Tissues sections pro-
cessed in the same fashion without the addition of primary
antisera were used as negative controls.
Localization of MMP-9 transcriptional activity
with cell-specific markers. For colocalization studies,
2-week TAAs were surgically induced in three additional
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with three age-matched unoperated-on reference control
mice. At the time of terminal surgery, the animals were
euthanized and perfused with normal saline as before. The
aorta was then perfused with 10% formalin for 5 minutes,
and the whole animal was incubated in 10% formalin for 48
hours at 4°C. The treated region of the descending thoracic
aorta was then excised from the mouse, incubated in X-gal
as indicated previously, and stored at 4°C until they were
paraffin-embedded and sectioned (3-m cross-sections).
The aortic tissue sections were mounted on glass slides,
blocked with 3% bovine serum albumin, and reacted with
antisera specific for -smooth muscle actin (-SMA) (anti-
-SMA, rabbit, 1:250; Abcam, #Ab5694, Cambridge,
Mass), discoidin domain receptor 2 (DDR2; anti-DDR2,
goat, 1:250; Santa Cruz Biotechnology, #SC7555, Santa
Cruz, Calif), macrophages (anti-MAC3, rat, 1:50; BD
PharMingen, #550292, San Diego, Calif), or neutrophils
(anti-CD11b, rat, 1:50; BD PharMingen, #550282).
The slides were washed and reacted with a 1:200 dilu-
tion of primary antibody species-specific peroxidase conju-
gated secondary antibody (Vectastain ABC kit, Vector
Labs). Staining was visualized by incubation with DAB,
which formed a brown precipitate upon reaction with the
peroxidase-conjugated secondary antibody. Tissues sec-
tions processed in the same fashion, but without the addi-
tion of primary antisera, were used as negative controls.
Microscopy. Microscopic images of the stained tissue
sections were captured under10 (light green stain),40
(-gal and MMP-9 imaging), or 63 (light green, cell
specific markers) magnification on a Zeiss Axioscop 2 mi-
croscope (Carl Zeiss MicroImaging Inc, Thornwood, NY)
equipped with an AxiocamMRc cooled color CCD camera
connected to a computer running AxioVision Software 4.2
(Zeiss).
Quantitation of MMP-9 mRNA. MMP-9 mRNA
levels were determined in two separate cohorts of mice.
Two-week TAAs were surgically induced in wild-type
CD-1 mice (n  6) and transgenic MMP-9 reporter mice
(n 6). Relative levels of MMP-9mRNAwere quantitated
and compared with unoperated-on control groups of wild-
type CD-1 (n  6) and transgenic MMP-9 reporter mice
(n  6). The descending thoracic aortas were harvested,
rinsed in phosphate-buffered saline, and placed immedi-
ately into RNAlater solution (Ambion, Inc, Austin, Texas)
for 24 hours at 4°C.
The tissue was homogenized and total RNA was ex-
tracted using the RNeasy Fibrous Tissue Mini Kit (Qiagen,
Inc, Valencia, Calif) according to the manufacturer’s in-
structions. The RNA was then assessed for quality and
quantity using the Experion Automated Electrophoresis
System (Bio-Rad Laboratories, Hercules, Calif). High-
quality RNA was reverse transcribed using an iScript cDNA
Synthesis kit (Bio-Rad Laboratories). MMP-9 mRNA lev-
els were then determined by quantitative real-time poly-
merase chain reaction (QPCR) using a Taqman protocol.
Primer and probes were supplied in the Taqman Gene
Expression Assays on Demand for MMP-9 and 18S ribo-somal RNA (rRNA; Applied Biosystems, Foster City,
Calif). Equal amounts of complimentary DNA (cDNA; 2.5
L) generated from each aorta were used in each reaction,
andMMP-9 levels were determined and normalized to 18S
rRNA levels from each respective aorta.
Data analysis. Terminal aortic size was expressed as a
percentage increase from baseline size in each mouse. The
mean percentage change at each time point was then de-
termined and compared with the unoperated-on reference
control group. This study analyzed aortic diameters in
58.3% male and 41.7% female mice. Analysis of variance
(ANOVA) was performed on aortic diameter measure-
ments using gender as a covariate. The results revealed no
significant interaction with respect to gender (F 0.01 and
P .9424); therefore, the data derived from bothmale and
female mice were pooled for all subsequent analyses.
MMP-9 transcriptional activation and protein content
were determined as a percentage of positive staining to total
tissue present. From each mouse aorta (n 6) at each time
point (unoperated-on reference control, 1 week, 2 weeks,
and 4 weeks), three independent sections were analyzed
and images were captured from three separate fields, gen-
erating nine independent images from each aorta. The area
corresponding to active MMP-9 transcriptional activity
(blue staining) or MMP-9 protein content (brown stain-
ing) was determined by digital planimetry (SigmaScan 4.0,
Systat Software, Point Richmond, Calif). Results from each
of the nine images were averaged to provide a single value
for each aorta. The mean value for each TAA group was
then used to determine a percentage of change from the
unoperated-on reference control group. Relative levels of
MMP-9mRNA (normalized to 18S rRNA) were calculated
by the standard curve method and expressed as a percent
change from wild-type CD-1 control mice.
Statistical calculations were performed using the Stata 8
statistical software package (StataCorp LP, College Station,
Texas). Aortic diameter results, amount of -gal staining,
MMP-9 protein abundance, and QPCR results were ex-
pressed as a percentage of baseline or values from the
unoperated-on reference controls, and were compared by
using a one-sample, two-tailed, t test vs a fixed value of 100.
Pair-wise comparisons between groups were performed by
one-way ANOVA with post hoc Tukey’s wholly significant
difference calculations. All data are presented as a mean 
SEM, and values of P  .05 were considered to be statisti-
cally significant.
RESULTS
Aortic diameter measurements revealed that aortic di-
latation, consistent with the early stages of TAA formation,
was evident at 1 week after calcium chloride exposure,
reached a maximum at 2 weeks (21%  6% increase from
baseline, P .05), and remained dilated at 4 weeks (18%
4% increase from baseline, P  .05) without a further
increase in size (Fig 1, A). Flattening and thinning of the
medial elastic lamellae was observed, as were the early
stages of elastin degradation (Fig 1, B).
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tional activation during TAA formation was determined by
staining for -gal in MMP-9 reporter mice (Fig 2). MMP-9
transcriptional activation was evident within the periadven-
titial adipose layer at 1 week post-TAA induction. Tran-
scriptional activity was increased at 2 weeks post-TAA in-
duction, demonstrating significant adventitial -gal staining,
and was diminished at 4 weeks post-TAA induction. Quan-
titation of total -gal staining within multiple tissue sec-
tions was performed as described using digital planimetry.
The data revealed an increase in -gal staining at 1 week
post-TAA induction, which reached a maximum at 2
weeks, and returned to control values at 4 weeks (Fig 3).
Time-dependent localization of MMP-9 protein was
likewise assessed during TAA formation by immunohisto-
chemical staining (Fig 4). Increased MMP-9 protein con-
tent was evident within the aortic adventitia at 2 weeks
post-TAA induction; whereas at 4 weeks, enhanced
MMP-9 staining was observed at the medial–adventitial
border and within the elastic medial layers. Quantitation of
total endogenous MMP-9 protein from multiple tissue
sections was performed as described using digital planim-
etry. A significant increase in MMP-9 content was demon-
strated at 2 weeks and 4 weeks post-TAA induction, with
minimal staining quantitated in the control and 1-week
Fig 1. Aortic dilatation and architecture. A, Aortic diameters
were measured in each mouse at baseline and terminal surgery.
Aortic diameters increased at 1 week, reached a maximum at 2
weeks, and remained dilated at 4 weeks post-thoracic aortic aneu-
rysm (TAA) induction (n  6 at all time points). *P  .05 vs
baseline; #P  .05 vs 1 week post-TAA. Data shown are mean 
SEM. B, Cross-section of aorta at 2 weeks post-TAA induction
counterstained with light green. Low magnification image reveals
thinning and flattening of medial elastic lamellae (left, arrows). The
red box outlines an area of highmagnification that reveals flattening
and early disruption of elastic lamellae (right, arrows). Scale bars
are indicated on each image.samples (Fig 5).Colocalization of MMP-9 transcriptional activity with
cell-type specific markers 2 weeks post-TAA revealed that
MMP-9 transcriptional activity, as determined by X-gal
staining, colocalized with -SMA (smooth muscle cells/
Fig 2. Localization of -galactosidase. Matrix metalloproteinase-9
transcriptional activity was localized by staining for -galactosidase
activity at the indicated time points after thoracic aortic aneurysm
(TAA) induction. Representative images from 8 m longitudinal
sections are shown. Diffuse -galactosidase staining was observed
within the periadventitial adipose layer at all time points post-TAA
induction. -Galactosidase staining was elevated within the adven-
titia 2 weeks post-TAA induction (AL, Aortic lumen; bar 50 m).
Fig 3. Quantitation of total -galactosidase activity. The amount
of blue precipitate formed from the conversion of X-gal by -
galactosidase was quantitated by digital planimetry at the indicated
time points. -Galactosidase staining was evident at 1 week after
thoracic aortic aneurysm (TAA), reached a maximum at 2 weeks
post-TAA, and returned to baseline at 4 weeks post-TAA (n 6 at
all time point). *P  .05 vs 100; P  .05 vs 4 weeks post-TAA.
Data shown are mean  SEM.myofibroblasts) and DDR2 (fibroblasts). No colocalization
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trophils) (Fig 6).
Quantitative real-time PCR was performed to measure
Fig 4. Localization of matrix metalloproteinase 9 (MMP-9).
MMP-9 protein was immunolocalized at the indicate time points
after thoracic aortic aneurysm (TAA) induction. Representative
images from 8-m longitudinal sections are shown. Diffuse
MMP-9 staining was observed throughout the tissue specimens at
all time points. Enhanced MMP-9 protein levels were observed at
2 weeks post-TAA induction within the adventitia. At 4 weeks
post-TAA induction, MMP-9 protein content was elevated at the
medial–adventitial border, as well as throughout the elastic layers
of the media (AL, Aortic lumen; bar  50 m).
Fig 5. Quantitation of matrix metalloproteinase 9 (MMP-9) pro-
tein content. The amount of brown staining, corresponding to the
amount MMP-9 protein, was quantitated by digital planimetry at
the indicated time points. A significant increase in MMP-9 protein
abundance was observed at 2 weeks after thoracic aortic aneurysm
(TAA) and remained elevated from reference control at 4 weeks
post-TAA (n  6 at all time points). *P  .05 vs 100, #P  .05 vs
1 week post-TAA. Data shown are mean  SEM.MMP-9 mRNA in descending aortas of unoperated-oncontrols and 2-week TAA mice in the MMP-9 reporter
strain and its nontransgenic CD-1 background strain.
MMP-9 mRNA levels were elevated at 2 weeks post-TAA
induction in both the CD-1 (464.9%  90.1%, P  .05 vs
100%) and MMP-9 reporter mice (291.8%  57.0%, P 
.05 vs 100%).
DISCUSSION
Degenerative changes occurring within the vascular
wall are a common feature of all aortic aneurysms.8 These
changes include remodeling of the vascular extracellular
matrix (ECM) and smooth muscle cell apoptosis, and are
often associated with the activation of resident and circu-
lating inflammatory cells.20 As vital mediators of ECM
Fig 6. Localization of -galactosidase activity with cell-type spe-
cific markers. Areas with increased -galactosidase activity (indi-
cated by blue X-gal staining) were colocalized with cell-type spe-
cific markers on 3 m cross-sections of aortic tissue harvested 2
weeks after thoracic aortic aneurysm (TAA) induction. The cell-
type markers -smooth muscle actin (SMA), fibroblasts (discoi-
din domain receptor 2, DDR2), macrophages (MAC3) and neu-
trophils (CD11b) were immunolocalized and visualized by brown
3,3=-diaminobenzidine staining. Images were taken with 63
objective under oil (Plan-NEOFLUAR, 1.25 NA). Representative
images of three independent sections are shown. The red box
outlines an area of high magnification image located to the right.
Scale bars are indicated on each image.remodeling, the MMPs have been implicated in the patho-
JOURNAL OF VASCULAR SURGERY
Volume 44, Number 6 Jones et al 1319genesis of aneurysm formation, and MMP-9 has been
identified in both the abdominal and thoracic aorta as a vital
participant in this process.12,14,15,17,21
Accordingly, the present study builds upon these past
observations by revealing the spatiotemporal localization of
MMP-9 transcriptional activity and protein content in situ
in an experimental murine model of thoracic aortic aneu-
rysms (TAAs). The unique findings from this study dem-
onstrated increased MMP-9 transcriptional activity within
the adventitia and at the border of the adventitial and
medial layers at 2 weeks post-TAA induction, which local-
ized to endogenous cells within the vascular wall. This was
accompanied by a concomitant increase in MMP-9 protein
content, also within the aortic adventitia. At 4 weeks post-
TAA induction, despite the return of MMP-9 transcrip-
tional activation to baseline, increased MMP-9 protein
content was observed at the medial–adventitial border and
throughout the medial elastic lamellae. These findings thus
suggest that in the early stages of aortic dilatation, MMP-9
is produced by native smooth muscle cells/myofibroblasts
and fibroblasts. This early response may then provide a
means by which activated circulating and resident inflam-
matory cells may further infiltrate the vascular wall and
drive aneurysm formation.
To localize MMP-9 transcriptional activity within the
thoracic aorta in the early stages of aneurysm formation,
TAAs were surgically induced in transgenic MMP-9 re-
porter mice18 and observed during the initial 4 weeks of
aneurysm formation. These mice carry, in addition to the
endogenous MMP-9 gene, a transgene that drives -gal
production under the control of the MMP-9 promoter.
The presence of this transgene did not affect normal
mouse development or the inducibility of the endogenous
MMP-9 transcript, as determined in the present study by
quantitative PCR.
Aortic outer diameter increased significantly within 1
week after TAA induction surgery and reached a maximal
diameter at 2 weeks. Changes in aortic architecture at 2
weeks were evident and characterized by early signs of
medial disruption indicated by flattening and thinning of
the elastic lamellae. These observations were consistent
with previous reports of calcium chloride–induced elastic
lamellar disruption in AAAs.22 At 4 weeks post-TAA induc-
tion, the aortic diameter was not significantly different from
the 2-week time point, suggesting that dilatation reached a
plateau.
To determine the localization of active MMP-9 tran-
scription, -gal activity in explanted aortas was identified in
situ by reaction with the colorimetric substrate X-gal. Be-
cause the -gal enzyme has a very short half-life upon
translation, estimated at 13 hours in fibroblasts,23 X-gal
staining reveals recent transcriptional activity within the
tissue samples, thus allowing quantitation and localization
simultaneously. The results demonstrated that -gal was
clearly elevated within the aortic adventitia at 2 weeks
post-TAA induction. Furthermore, when MMP-9 was
immunolocalized within the tissue specimen, increasedMMP-9 protein abundance was also observed within the
adventitial layer at 2 weeks after surgery.
Because MMP-9 can be synthesized by a number of
different cell types found within the aortic vascular
wall,20,24 and because of the direct implication of MMP-9
production by infiltrating macrophages in AAA develop-
ment,14,15 it became important to identify the cell types
actively transcribing MMP-9 during TAA formation. To
accomplish this, TAAs were induced in MMP-9 reporter
mice and the aortas were harvested at 2 weeks and reacted
with X-gal. Three micrometer cross-sections of aortic tissue
were used to colocalize -gal activity with specific cell-type
markers: smooth muscle cells/myofibroblasts (-SMA),25
fibroblasts (DDR2),26 macrophages (MAC3),27 and neu-
trophils (CD11b).28 Interestingly, -gal activity colocal-
ized with -SMA and DDR2 cell markers, indicating that
MMP-9 was being produced by smooth muscle cells/
myofibroblasts and fibroblasts present in the aortic adven-
titia.
These results advance and are in direct agreement with
the previous observation by Koullias et al29 that suggested
that MMP-1 and MMP-9 were produced by endogenous
smooth muscle cells within the aortic vascular wall in sam-
ples collected from patients with TAA or thoracic aortic
dissections. Surprisingly, no colocalization of X-gal staining
was observed with MAC3 or CD11b, however, suggesting
that either resident/circulating inflammatory cells do not
participate in early aortic dilatation events or simply that
these cells types were not actively transcribing MMP-9.
At 4 weeks post-TAA induction, immunolocalization
of MMP-9 revealed increased MMP-9 protein content at
the medial–adventitial border and throughout the elastic
medial layer. An important finding was that this occurred
in the absence of significant -gal production, suggesting
that the MMP-9 present was not the result of recent
transcriptional activation. Several possibilities exist that
may explain the presence of MMP-9 in the absence of
MMP-9 transcriptional activity:
1. The mouse model used for these studies relies on X-gal
staining of active -gal to identify regions of active
MMP-9 transcription. Because the half-life of the -gal
protein is very short and the half-life of MMP-9 protein
remains unknown, it is possible that -gal staining pre-
ceded the increase in MMP-9 but was missed owing to
the timing of tissue processing.
2. Both neutrophils and macrophages are known to con-
tain preformed stores of pro-MMP-9, so it is possible
that release of intracellular stores ofMMP-9 could occur
in the absence of active MMP-9 transcription. Thus,
local MMP-9 levels would be elevated as the result of
macrophage/neutrophil degranulation.
3. The increased MMP-9 protein content in the absence of
new transcription could be the result of an increase in
MMP-9 mRNA stability. A study by Liu et al30 previously
demonstrated that the use of doxycycline, a broad-spec-
trum MMP inhibitor, reduced MMP-2 production and
abundance by a mechanism that resulted in decreased
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Huwiler et al31 demonstrated that MMP-9 expression was
amplified by extracellular adenosine triphosphate in re-
sponse to interleukin-1 by a mechanism involving in-
creased MMP-9 mRNA stability. Iyer et al32 likewise dem-
onstrated that MMP-9 mRNA stability was enhanced in
response to activation of the mitogen-activated protein
kinase pathway and that the 31 integrin was required
posttranscriptionally to maintain mRNA levels. The net
outcome of increased steady-state mRNA levels in both
cases was a net increase in MMP-9 translation in the
absence of new MMP-9 transcription.
4. The periadventitial adipose layer may function as a
storehouse for latent MMPs capable of diffusing into
the aortic media. Bouloumié et al33 established that
MMP-2 and MMP-9 could be produced in adipocytes
and that expression of each was enhanced during adipo-
cyte differentiation. Interestingly, at all time points
post-TAA induction, diffuse -gal staining was observed
within the adventitial adipose tissue, suggesting that the
adipose layer may function as a source for MMP-9
during aneurysm formation. Additional studies are re-
quired to address these possibilities.
Together, these data bring into question the hypothesis
that infiltrating inflammatory cells are the critical source of
MMP-9 in early dilatation events during TAA develop-
ment. These data clearly show that endogenous fibroblasts,
and possibly smooth muscle cells, at least contribute to
MMP-9 production during TAA formation and suggest
that further study of these specific cell types may allow the
identification of specific signaling pathways that stimulate
MMP-9 production. Previous studies have identified that
degraded elastin fragments are chemotactic for macro-
phages and neutrophils.34 It is thus conceivable that early
signaling events stimulate MMP production in native cells
within the aorta, and an inflammatory response ensues as a
result of early remodeling events (ie, elastin degradation).
The role of resident/circulating macrophages and neu-
trophils cannot, however, be discounted. Previous evidence
in murine models of AAA demonstrate a requisite role for
macrophage-derived MMP-9 in aneurysm formation.15
Additionally, recently published data from our laboratory
have identified neutrophil collagenase (MMP-8) and mac-
rophage metalloelastase (MMP-12) in homogenates of
murine TAAs at early time points after TAA induction.35
Hence, a strong case exists suggesting that inflammatory
infiltrate may contribute to aneurysm formation in the
thoracic aorta as well as in the abdomen. Also of interest is
the intriguing possibility that adipocyte-derived MMP-9
may contribute to TAA formation. Additional studies will
be required to address these questions more specifically.
Because this study focused on in situ methodology for
identification and localization of MMP-9 transcriptional
activity and protein abundance, it is not without limita-
tions. First, digital planimetry was used to quantitate the
histochemical and immunologic staining of aortic tissue
sections. It is recognized that this methodology is onlysemi-quantitative; hence, care must be taken to not over-
interpret the ability to quantitate MMP-9 in these tissues.
All the same, the strength of this technique is the ability to
localize transcriptional activity and protein content.
Second, the antibody used in this study recognized
both pro and active forms of MMP-9; thus, care must be
taken to not directly equate MMP-9 protein abundance
with MMP-9 activity. Subsequent studies are warranted to
directly assess the spatiotemporal localization of MMP
proteolytic activity with the aortic wall during aneurysm
formation. Moreover, the use of MMP-reporter mice com-
bined with the use of MMP inhibitors, such as doxycycline,
could substantially advance our understanding of how
MMP inhibitors mechanistically affect aortic dilatation dur-
ing aneurysm development.
Third, it must also be noted that antibodies that recog-
nize -SMA cannot differentiate between smooth muscle
cells and myofibroblasts; hence, SMA cells may consist
of both cell types.25
Fourth, the present study revealed the spatiotemporal
localization ofMMP-9 transcriptional activity and abundance
within the aortic wall during the early dilatation events occur-
ring with TAA formation. A significant gender interaction
with respect to aortic dilatation could not be demonstrated,
thus all data were pooled before analysis. Whether gender-
dependent differences in aortic dilatation exist and could be
associated with different patterns of MMP-9 transcriptional
activity or abundance remains to be established.
Last, although this murine model of TAA recapitulates
many of the hallmarks of human aneurysmal disease, care
should be taken in the extrapolation of these results to
human TAAs.
CONCLUSION
Despite the study limitations, the data clearly demonstrate
time-dependent changes in the localization of MMP-9 tran-
scriptional activity and protein abundance early in the
course of aortic dilatation during TAA formation. To our
knowledge, these results demonstrate for the first time that
MMP-9 is produced by smooth muscle cells/myofibro-
blasts and fibroblasts resident within the aortic vascular
wall. Thus, early aortic dilatation may be driven by activa-
tion of the endogenous cells to produce MMP-9, which
may provide a means for subsequent inflammatory cells to
infiltrate and invade the adventitial and medial layers lead-
ing to greater aortic expansion and aneurysm formation.
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